Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review

作者
Shengyu Zhou,Guanxing Sun,Jianwei Wang,Hongtu Zhang
出处
期刊:Translational Andrology and Urology [AME Publishing Company]
卷期号:9 (6): 2855-2861 被引量:14
标识
DOI:10.21037/tau-20-1343
摘要

Renal cell carcinoma (RCC) with anaplastic lymphoma kinase (ALK) rearrangement is rare, and the genetic profiles of the tumor have not been elucidated. Here, we report a case with recurrent papillary RCC and lung metastasis after nephrectomy for nearly 7 years. The patient first received sunitinib, whereas the drug toxicity was intolerable. Combined Immunohistology (IHC) and fluorescence in situ hybridization (FISH) revealed the patient has an ALK rearrangement, and the patient then was treated with crizotinib. The patient had good tolerance, and a partial response in the target lesions was achieved. In order to further understand the benefit of crizotinib in ALK-rearranged RCC, the patient was detected with whole exome sequencing (WES) to study her genetic profiles. Compared those of RCC cases without ALK rearrangement (nALK-RCC), the patient and nine RCC cases with ALK rearrangement (ALK-RCC) revealed unique genetic characteristics: 1) The common mutations that occurred in RCC were not found in ALK-RCC.; 2) A total of 11 co-existing mutations in ALK-RCC were found, and they occurred in nALK-RCC at a relatively low frequency. DNMT3A mutations were concurrent with ALK fusions in our case. These findings indicated a different genetic alteration pattern of ALK-RCC from nALK-RCC. Our case demonstrated the efficacy of crizotinib in an RCC patient with ALK rearrangement.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
酷波er的应助被zx采纳,获得10
1秒前
搜集达人的应助被AUK采纳,获得10
1秒前
2秒前
往不随发布了新的文献求助10
2秒前
WZJ发布了新的文献求助10
2秒前
2秒前
bronny完成签到,获得积分20
5秒前
JeanetteJin发布了新的文献求助10
5秒前
CipherSage的应助被勤恳的铲丝采纳,获得10
5秒前
在水一方的应助被succo采纳,获得10
5秒前
xxxg郭完成签到 ,获得积分10
6秒前
6秒前
琪琪发布了新的文献求助10
6秒前
7秒前
7秒前
赘婿的应助被ayzzdbr采纳,获得10
7秒前
cdercder的应助被而非哈随哈桑采纳,获得10
7秒前
Luuuuu的应助被而非哈随哈桑采纳,获得10
8秒前
传奇3的应助被而非哈随哈桑采纳,获得10
8秒前
大个的应助被而非哈随哈桑采纳,获得10
8秒前
丘比特的应助被而非哈随哈桑采纳,获得10
8秒前
8秒前
华仔的应助被1128采纳,获得10
9秒前
英俊的铭的应助被liurong采纳,获得10
9秒前
bronny发布了新的文献求助10
10秒前
10秒前
mengya00完成签到,获得积分10
11秒前
12秒前
12秒前
12秒前
12秒前
13秒前
YAMABUKI完成签到,获得积分10
13秒前
13秒前
NexusExplorer的应助被外向夜阑采纳,获得10
13秒前
zzschnappi发布了新的文献求助10
14秒前
大模型的应助被平淡的帆布鞋采纳,获得10
14秒前
14秒前
TTORSH完成签到,获得积分10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177654
求助须知:如何正确求助?哪些是违规求助? 9568503
关于积分的说明 21799551
捐赠科研通 7772253
什么是DOI,文献DOI怎么找? 3432428
关于科研通互助平台的介绍 2556594
邀请新用户注册赠送积分活动 2478011